Recall Register

Food, drugs, devices › The Magstim Company Limited

Device recall: Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated for use in stimulating an

FDA enforcement event 87063 · Class II · initiated 8 Dec 2020 · status Terminated · terminated 16 Feb 2023

DeviceVoluntary: Firm initiated1 product recordWhitland, N/A

FDA enforcement event 87063 is a device recall by The Magstim Company Limited of Whitland, N/A, initiated 8 Dec 2020 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Terminated, terminated 16 Feb 2023. Initiation: voluntary: firm initiated. The Magstim Company Limited has 5 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

The Magstim Company Limited, Whitland, N/A, United Kingdom.

Reason for recall

"A small number of Neurosign 100 Intraoperative Nerve Monitors may have been dispatched without being configured appropriately for the supply mains within the target Country. The specific deficiency includes: 1. Onboard voltage selector set to 240V (European Standard), versus 120V requirement for the United States and Canada. 2. Fuses installed in the Power Entry Module (PEM) 2xT315mAL (240V…"

Distribution

"MN, NC, and NY"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0869-2021Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated for use in stimulating and monitoring cranial motor nerves, especially the facial nerve (VII), during ENT surgical procedures.7 unitsClass IITerminated27 Jan 2021

Context

93%of 2020 device events are Class II916 events that year
1product record in this eventfirm median: 1
5events on this register for the firm

Other enforcement events for The Magstim Company Limited

InitiatedProduct (first record)TypeClassRecords
23 Jun 2020Neurosign V4 Intraoperative Nerve monitor family of devices.DeviceClass II1
23 Mar 2020Horizon PSU Stim Interconnecting Cable - Product Usage: Horizon is indicated for the treatment of Major Depressive DisorDeviceClass II2
25 Oct 2018HORIZON Ez Arm (Part of the HORIZON TMS Therapy System.)DeviceClass II1
28 Sep 2017Magstim Rapid Therapy System consisting of: Rapid Mainframe, Rapid Single Power Supply Unit , Rapid User Interface, Air DeviceClass II1

All 5 events for The Magstim Company Limited

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "A small number of Neurosign 100 Intraoperative Nerve Monitors may have been dispatched without being configured appropriately for the supply mains within the target Country. The specific deficiency includes: 1. Onboard voltage selector set to 240V (European Standard), versus 120V requirement for the United States and Canada. 2. Fuses installed in the Power Entry Module (PEM) 2xT315mAL (240V…"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "MN, NC, and NY"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 16 Feb 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.